Non-invasive hybrid diffuse reflectance spectroscopy (HDRS) SPF methods, in line with the proposed ISO 23698 standard, are currently being evaluated as an alternative to in vivo SPF testing to provide UVAPF and SPF values while eliminating the ethical and safety considerations present with current in vivo erythema testing methods.
Solar Light has developed this revolutionary technology, the DRS Polychromatic (Poly602) and DRS Monochromatic (Mono602) systems, which can be used today as in vivo screening tools for development purposes.
As the world leader in SPF measurement, Solar Light has developed the highest-performing DRS instruments on the market, with product research, formulation and clinical testing in mind. HDRSplus™ software is designed specifically for a clinical trial laboratory environment and simplifies all HDRS calculations.